- October 05, 2017
- Taiho Pharmaceutical Co., Ltd.
Taiho Pharmaceutical Releases Pitas Sore Throat Troche in Japan on October 5
A Sticker-type Troche to be Placed on the Roof of the Mouth That is Helpful in Business Meetings
Taiho Pharmaceutical Co., Ltd. announced today that on Thursday, October 5 it has launched throughout Japan the Pitas Sore Throat Troche (designated quasi-drug), a sticker-type troche to be placed on the roof of the mouth. It is effective against sore and swollen throats.
The thin sticker-type formulation makes it possible to take the troche without other people noticing, as it does not get in the way when speaking.
Listening to the voices of office workers who say, “Cough drops and conventional troches are hard to take in business meetings as well as when communicating with customers,” the company developed the troche by improving its usefulness in addition to effectiveness. It is also handy to carry around, as its thin package allows it to fit in a business card case or commuter-pass holder without making it bulky.
Taiho Pharmaceutical will continue to contribute to people’s health and happy lifestyles in Japan.
- Box of 12
- Individual packaging
For details of the Pitas Sore Throat Troche, visit the Pitas brand website below.
https://www.taiho.co.jp/chc/brand/pitas/ (In Japanese only)
For a limited time, the Pitas brand website is streaming an original Pitas video featuring artists such as Ayaka Hirahara, Anna Tsuchiya, KEN LLOYD, KEYTALK, and vistlip as well as a video in which eight Instagrammers who contribute to women’s fashion magazines demonstrate how to use Pitas.
Features of the Pitas Sore Throat Troche
1．A sticker-type troche to be placed in the mouth without taking water. It is useful in business meetings and when communicating with customers.
2．A thin package that is handy to carry around
3．Does not cause drowsiness
|Brand name||Pitas Sore Throat Troche|
|Risk categories||Designated quasi-drug|
|Suggested retail price||500 yen (excl. tax) for pack of 12|
|Active Ingredients||Cetylpyridinium chloride hydrate 8.28 mg (in six lozenges)|
|Indications||• Sore throat, swollen throat, throat irritation, discomfort and hoarseness due to throat inflammation.
• Oral sterilization/disinfection
• Elimination of bad breath
|Dosage and administration||15 years old and older: one troche 4 – 6 times daily
Under 15 years old: do not take
|Launch date||Launched throughout Japan on Thursday, October 5, 2017|
|Manufacturer||Kyukyu Pharmaceutical Co., Ltd.|
|Distributor||Taiho Pharmaceutical Co., Ltd.|
Information in this news release was current as of the original release date.